Respira Labs Secures $2.8M to Expand Clinical-Grade Respiratory Health Wearable

Respira Labs is a medical technology company that has been awarded $1M pre-seed funding led by Zentynel Frontier Investments, with participation by VentureWell, ImpactAssets and several angel investors from the United States and Latin America, and $2.8M in grants from Small Business Innovation Research (SBIR), The National Science Foundation (NSF), the National Institutes for Health (NIH) and other startup prizes.
Many investors are looking closely at Dr. Maria Artunduaga’s (founder and CEO of Respira Labs) work, as respiratory diseases have become the main cause of death in the U.S. since the COVID-19 pandemic. Currently, the devices available in the market fail to detect up to 50% of respiratory exacerbations, and hospitalizations and late diagnosis are increasing, a situation which makes Sylvee a promising solution for patients to monitor their own health at home, get earlier treatment and prevent hospitalizations.
Open Link